Press Release Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricides NanoViricides · Sep 15
Press Release COGENT COMMUNICATIONS HOLDINGS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 21, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline Bernstein Liebhard LLP · Sep 15
Press Release Braeburn Announces Publication of Postmarketing Safety Analysis Evaluating BRIXADI® in The Journal of Substance Use & Addiction Treatment Braeburn · Sep 15
Press Release Keystone Enters California Market with Acquisition of Infinity Assurance Group Keystone Agency Partners · Sep 15
Press Release Ritual Launches Perimenopause Health, comprehensive perimenopause support without any added hormones Ritual · Sep 15
Press Release FLORIDA BREAST CANCER FOUNDATION INVESTS $146,440 IN PROGRAMS REACHING WOMEN ACROSS FLORIDA Written By: EIN Presswire · Sep 15
Press Release AI Infrastructure: The Trillion-Dollar Market Growing Behind the AI Revolution MarketNewsUpdates.com · Sep 15
Press Release Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation Ensysce Biosciences · Sep 15
Press Release Blimpin’ Ain’t Easy, but It Just Got a Lot Easier The Goodyear Tire & Rubber Company · Sep 15
Press Release AT&T Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMD AT&T · Sep 15
Press Release Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care Femasys Inc. · Sep 15
Press Release KORTUC Achieves Target Enrollment in Registrational Breast Cancer Trial as Three Global Clinical Programs Advance KORTUC INC. · Sep 15
Press Release NewLake Capital Partners Declares Third Quarter 2026 Common Stock Dividend of $0.43 per Share NewLake Capital · Sep 15